1![FDA Briefing Document for the Cardiovascular and Renal Drugs Advisory (CRDAC) Meeting Date: 13 September 2012 FDA Briefing Document for the Cardiovascular and Renal Drugs Advisory (CRDAC) Meeting Date: 13 September 2012](https://www.pdfsearch.io/img/a74d688191299ef3a7a6c55f2d1669a5.jpg) | Add to Reading ListSource URL: www.fda.govLanguage: English |
---|
2![Microsoft Word - FINAL FDA Errata CRDAC for Lixivaptan[removed]doc Microsoft Word - FINAL FDA Errata CRDAC for Lixivaptan[removed]doc](https://www.pdfsearch.io/img/a77d72ad850f2da676d74fd07404bc7e.jpg) | Add to Reading ListSource URL: www.fda.govLanguage: English |
---|
3![Cardiokine Biopharma, LLC Lixivaptan Briefing Document NDA 203,009 Page 1 of 61 Cardiokine Biopharma, LLC Lixivaptan Briefing Document NDA 203,009 Page 1 of 61](https://www.pdfsearch.io/img/6b5f042e2ba3bf849ece8ed4eeb9d4cb.jpg) | Add to Reading ListSource URL: www.fda.govLanguage: English |
---|
4![Summary Minutes of the Cardiovascular and Renal Drugs Advisory Committee September 13, 2012 Location: FDA White Oak Campus, Building 31, the Great Room, White Oak Conference Center (Room 1503), Silver Spring, MD All exte Summary Minutes of the Cardiovascular and Renal Drugs Advisory Committee September 13, 2012 Location: FDA White Oak Campus, Building 31, the Great Room, White Oak Conference Center (Room 1503), Silver Spring, MD All exte](https://www.pdfsearch.io/img/b99c8cc5fea0ebd1ec23093257964370.jpg) | Add to Reading ListSource URL: www.fda.govLanguage: English |
---|
5![FOOD AND DRUG ADMINISTRATION FOOD AND DRUG ADMINISTRATION](https://www.pdfsearch.io/img/5cc640450565f4f9660b922abe69cdf5.jpg) | Add to Reading ListSource URL: www.fda.govLanguage: English |
---|
6![Microsoft Word - DRAFT Lixivaptan CRDAC Questions[removed]doc Microsoft Word - DRAFT Lixivaptan CRDAC Questions[removed]doc](https://www.pdfsearch.io/img/de38c4b589b3aedb9e85eec4cac0e9af.jpg) | Add to Reading ListSource URL: www.fda.govLanguage: English |
---|
7![FOOD AND DRUG ADMINISTRATION FOOD AND DRUG ADMINISTRATION](https://www.pdfsearch.io/img/58d0092f93467004397a713bc775d4bf.jpg) | Add to Reading ListSource URL: www.fda.govLanguage: English |
---|
8![Microsoft Word[removed]FDA Cardiovascular and Renal Drugs Advisory Committee - Morning Session - Final[removed]Version _Full Microsoft Word[removed]FDA Cardiovascular and Renal Drugs Advisory Committee - Morning Session - Final[removed]Version _Full](https://www.pdfsearch.io/img/1cd40c606ac0e04dc8c9fca87e3a5fba.jpg) | Add to Reading ListSource URL: www.fda.govLanguage: English |
---|
9![Microsoft Word - DRAFT Agenda CRDAC[removed]NV edits.doc Microsoft Word - DRAFT Agenda CRDAC[removed]NV edits.doc](https://www.pdfsearch.io/img/04955017a8b63485e005ab27ee80c5e4.jpg) | Add to Reading ListSource URL: www.fda.govLanguage: English |
---|